SERDA therapeutics
SERDA Therapeutics develops a wound debridement solution specifically designed to treat severe burn injuries and persistent ulcers.
Based based in European Union (EU), Europe, Middle East, and Africa (EMEA), SERDA therapeutics works in pharmaceutical, founded in 2020.
SERDA therapeutics is positioned in pharmaceutical, a segment that rewards a clear, focused offering.
The company is recorded as being based in European Union (EU), Europe, Middle East, and Africa (EMEA).
Directory data places it at the Seed stage.
Its team size is recorded as c_00001_00010 employees.
It has disclosed roughly $2M in funding.
| Sector | Pharmaceutical |
|---|---|
| Headquarters | European Union (EU), Europe, Middle East, and Africa (EMEA) |
| Founded | 2020 |
| Employees | c_00001_00010 |
| Stage | seed |
| Total funding | $2,000,000 |
Website: serda-therapeutics.com
Browse related
Sign in to view the contact information we hold for SERDA therapeutics.
Create a free account
Create a free account